Novo

Business

Novo Nordisk shares tumble as weight-loss drug trial data disappoints

Unlock the Editor’s Digest for free Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter.…

Read More »
Business

Catalent and Novo Holdings Fulfill All Regulatory Closing Conditions for Pending Transaction By Investing.com

Transaction (JO:) Expected to Close in the Coming Days SOMERSET, N.J. & COPENHAGEN, Denmark–(BUSINESS WIRE)–Catalent, Inc. (Catalent (NYSE:), NYSE: CTLT),…

Read More »
Business

This weight loss stock is the best alternative to Eli Lilly, Novo – SA Sentiment

Mario Tama/Getty Images News A recent poll of Seeking Alpha subscribers cited Amgen (NASDAQ:AMGN) as the next big obesity play…

Read More »
Back to top button